ProVenture

Geir Ove Kjesbu serves as Managing Partner and leads a six-partner team that makes all investment decisions collectively. Kjesbu previously spent eight years as CEO of Investinor, Norway's state-backed early-stage investor, and held senior roles at Q-Free ASA before joining ProVenture in 2018. The partnership includes former founders — Tom Arnøy took ZEDGE public on the NYSE — and industrial executives with decades of operating experience in oil services and R&D.

ProVenture sources exclusively within Norway, leaning heavily on the partnership's deep industrial and entrepreneurial networks in Trondheim, Stavanger, and Oslo. Because several partners are former startup CEOs and board chairs, much of the proprietary flow comes through founder referrals, academic spin-outs from NTNU, and connections built during decades in Norwegian oil, gas and technology services. The firm does not market a formal scout program or external advisory network.

ProVenture is structured as an asset manager — a private-equity firm running three commingled seed funds totaling 1.3 billion NOK. It is not a family office. Its limited-partner base is not publicly disclosed, but the firm operates on a conventional venture-fund model with a management company and six full-time partners.

ProVenture invests directly from its own balance sheet of funds and does not publicly disclose a fund-of-funds program or LP commitments into other venture firms. The firm's model is built on sourcing, diligencing, and holding direct equity stakes in Norwegian digital-technology startups from seed stage onward.

The firm writes checks at seed and early stages. Its portfolio is segmented into Seed I, Seed II, and Seed III vintages, indicating a series of early-stage vehicles rather than a growth-stage or buyout strategy. Selected exits — over 50 reported — suggest the firm typically holds positions until a trade sale or, in the case of ZEDGE, a public listing.

ProVenture does not publish an exclusion list. However, its stated focus on 'digital technology' and its portfolio pattern — SaaS, robotics, digital health, sensor fusion, energy modeling — suggest it avoids capital-intensive biotech, therapeutics, deep hardware manufacturing, and non-digital consumer goods.

The firm does not publicly describe a co-investment program or a history of syndicating deals with external general partners. Its website frames the partnership as the primary source of funding and operational support for portfolio companies, implying a lead-or-solo investor posture in the Norwegian seed market, though syndication likely occurs informally.